Lipotriad Visionary
Natural health product licensed in Canada
- Other names
- Liotraid Visionary Vitamins for Healthy Eyes
- Licence holder
- Lipotriad Vitamins LLC
- NPN or DIN-HM
- 80070063
- Status
- Active licence
- Licence date
- 8 June 2016
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 17.4 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bêta-carotene-3,3'-diol totalement trans- Source : Tagetes erecta - Fleur | 2.5 mg | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 50 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 125 mg Docosahexaenoic acid | Not specified | Not calculated |
| Vitamine C Source : Acide ascorbique | 113 mg | 113,000 µg |
| Zinc Source : Oxyde de zinc | 17.4 mg | 17,400 µg |
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 67 mg AT | Not calculated |
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 100 UI | Not calculated |
| Cuivre Source : Gluconate de cuivre (II) | 0.4 mg | 400 µg |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Tagetes erecta - Fleur | 10 mg | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 200 mg Omega-3 Fatty acids | 250 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Carmine, Glycérine, Cire d'abeille jaune, Lécithine, Caramel, Eau purifiée, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Antioxidant for the maintenance of eye health. Antioxidant for the maintenance of good health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Multi-vitamin and multi-mineral supplement. Vitamin and mineral supplement. Helps in connective tissue formation. Source of antioxidants that help reduce cell damage caused by free radicals. A factor in the maintenance of good health. Helps to produce and repair connective tissue.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80070063
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.